Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride

Journal of Dermatological Science

Volumn 56, Issue 1, 2009, Pages 43-50

  Hong, Hua ^a   Park, Yu Kyoung ^a   Choi, Mi Sun ^a   Ryu, Nam Hee ^a   Song, Dae Kyu ^a   Suh, Seong Il ^a   Nam, Ki Young ^a   Park, Gy Young ^b   Jang, Byeong Churl ^a  

^a Keimyung University School of Medicine   (South Korea)

^b Catholic University of Daegu   (South Korea)

Author keywords

COX 2; Glucosamine hydrochloride; Human skin fibroblasts; IL 1 ; MMP 13; PMA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; CYCLOOXYGENASE 2; GLUCOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TRANSCRIPTION TERMINATION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOGENS; CELL LINE; CYCLOOXYGENASE 2; DOWN-REGULATION; ENZYME INHIBITORS; FIBROBLASTS; GLUCOSAMINE; HUMANS; IMIDAZOLES; INTERLEUKIN-1BETA; KERATINOCYTES; MATRIX METALLOPROTEINASE 13; PROTEIN KINASES; PYRIDINES; SKIN; TETRADECANOYLPHORBOL ACETATE;

EID: 69049085443     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.06.017     Document Type: Article

References (53)

1. Hua J., Suguro S., Hirano S., Sakamoto K., and Nagaoka I. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res 54 (2005) 127-132
2. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
3. Nakamura H., Shibakawa A., Tanaka M., Kato T., and Nishioka K. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol 22 (2004) 293-299
4. Largo R., Alvarez-Soria M.A., Díez-Ortego I., Calvo E., Sánchez-Pernaute O., Egido J., et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11 (2003) 290-298
5. Smith W.L., and Dewitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62 (1996) 167-215
6. Vane J.R., Bakhle Y.S., and Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38 (1998) 97-120
7. Hla T., Ristimäki A., Appleby S., and Barriocanal J.G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 696 (1993) 197-204
8. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
9. Williams G.W. An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors. Curr Pain Headache Rep 9 (2005) 377-389
10. Herschman H.R., Reddy S.T., and Xie W. Function and regulation of prostaglandin synthase-2. Adv Exp Med Biol 407 (1997) 61-66
11. Newton R., Kuitert L.M., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 237 (1997) 28-32
12. Inoue H., Yokoyama C., Hara S., Tone Y., and Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270 (1995) 24965-24971
13. Ristimäki A., Garfinkel S., Wessendorf J., Maciag T., and Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 269 (1994) 11769-11775
14. Srivastava S.K., Tetsuka T., Daphna-Iken D., and Morrison A.R. IL-1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3'-untranslated region. Am J Physiol 267 (1994) F504-F508
15. Jang B.C., Muñoz-Najar U., Paik J.H., Claffey K., Yoshida M., Hla T., et al. an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem 278 (2003) 2773-2776
16. Nemeth J.F., Hochgesang Jr. G.P., Marnett L.J., and Caprioli R.M. Characterization of the glycosylation sites in cyclooxygenase-2 using mass spectrometry. Biochemistry 40 (2001) 3109-3116
17. Hla T., and Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 89 (1992) 7384-7388
18. Otto J.C., DeWitt D.L., and Smith W.L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J Biol Chem 268 (1993) 18234-18242
19. Mbonye U.R., Wada M., Rieke C.J., Tang H.Y., Dewitt D.L., and Smith W.L. The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J Biol Chem 281 (2006) 35770-35778
20. Kang Y.J., Mbonye U.R., DeLong C.J., Wada M., and Smith W.L. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46 (2007) 108-125
21. Jang B.C., Sung S.H., Park J.G., Park J.W., Bae J.H., Shin D.H., et al. Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner. J Biol Chem 282 (2007) 27622-27632
22. Mbonye U.R., Yuan C., Harris C.E., Sidhu R.S., Song I., Arakawa T., et al. Two distinct pathways for cyclooxygenase-2 protein degradation. J Biol Chem 283 (2008) 8611-8623
23. Chen W., Tang Q., Gonzales M.S., and Bowden G.T. Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes. Oncogene 20 (2001) 3921-3926
24. Hunot S., Vila M., Teismann P., Davis R.J., Hirsch E.C., Przedborski S., et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 101 (2004) 665-670
25. Jang B.C., Kim D.H., Park J.W., Kwon T.K., Kim S.P., Song D.K., et al. Induction of cyclooxygenase-2 in macrophages by catalase: role of NF-kappaB and PI3K signaling pathways. Biochem Biophys Res Commun 316 (2004) 398-406
26. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738-746
27. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
28. Manicone A.M., and McGuire J.K. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19 (2008) 34-41
29. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25 (2006) 9-34
30. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211 (2007) 19-26
31. Yokoo T., and Kitamura M. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol 270 (1996) F123-F130
32. Raymond L., Eck S., Mollmark J., Hays E., Tomek I., Kantor S., et al. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta. J Cell Physiol 207 (2006) 683-688
33. Vincenti M.P., and Brinckerhoff C.E. Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?. J Cell Physiol 213 (2007) 355-364
34. Yoshida N., Kanekura T., Higashi Y., and Kanzaki T. Bidens pilosa suppresses interleukin-1beta-induced cyclooxygenase-2 expression through the inhibition of mitogen activated protein kinases phosphorylation in normal human dermal fibroblasts. J Dermatol 33 (2006) 676-683
35. Wu N., Opalenik S., Liu J., Jansen E.D., Giro M.G., and Davidson J.M. Real-time visualization of MMP-13 promoter activity in transgenic mice. Matrix Biol 21 (2002) 149-161
36. Dasu M.R., Barrow R.E., Spies M., and Herndon D.N. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 29 (2003) 527-531
37. Shin Y., Yoon S.H., Choe E.Y., Cho S.H., Woo C.H., Rho J.Y., et al. PMA-induced up-regulation of MMP-9 is regulated by a PKCalpha-NF-kappaB cascade in human lung epithelial cells. Exp Mol Med 39 (2007) 97-105
38. Van Dross R.T., Hong X., and Pelling J.C. Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes. Mol Carcinog 44 (2005) 83-91
39. Largo R., Alvarez-Soria M.A., Díez-Ortego I., Calvo E., Sánchez-Pernaute O., Egido J., et al. Glucosamine inhibits IL-1beta-induced NF kappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 11 (2003) 290-298
40. Rafi M.M., Yadav P.N., and Rossi A.O. Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and transcription factor NF-kappaB. Mol Nutr Food Res 51 (2007) 587-593
41. Davidson M.B., Hunt K., and Fernandez-Mejia C. The hexosamine biosynthetic pathway and glucose-induced down regulation of glucose transport in L6 myotubes. Biochim Biophys Acta 1201 (1994) 113-117
42. Qiu W., Avramoglu R.K., Rutledge A.C., Tsai J., and Adeli K. Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins. J Lipid Res 47 (2006) 1749-1761
43. Imperiali B., and Hendrickson T.L. Asparagine-linked glycosylation: specificity and function of oligosaccharyl transferase. Bioorg Med Chem 3 (1995) 1565-1578
44. Comunale M.A., Mattu T.S., Lowman M.A., Evans A.A., London W.T., Semmes O.J., et al. Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. Proteomics 4 (2004) 826-838
45. Suzuki T., Park H., Hollingsworth N.M., Sternglanz R., and Lennarz W.J. PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase. J Cell Biol 149 (2000) 1039-1052
46. d'Abusco A.S., Calamia V., Cicione C., Grigolo B., Politi L., and Scandurra R. Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes. Arthritis Res Ther 9 (2007) R104
47. Lin Y.C., Liang Y.C., Sheu M.T., Lin Y.C., Hsieh M.S., Chen T.F., et al. Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways. Rheumatol Int 28 (2008) 1009-1016
48. Tindberg N., Porsmyr-Palmertz M., and Simi A. Contribution of MAP kinase pathways to the activation of ATF-2 in human neuroblastoma cells. Neurochem Res 25 (2000) 527-531
49. Rossa Jr. C., Liu M., Bronson P., and Kirkwood K.L. Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase. J Endotoxin Res 13 (2007) 85-93
50. Pham H., Vincenti R., and Slice L.W. COX-2 promoter activation by AT1R-Gq-PAK-p38beta signaling in intestinal epithelial cells. Biochim Biophys Acta 1779 (2008) 408-413
51. Jang B.C., Sanchez T., Schaefers H.J., Trifan O.C., Liu C.H., Creminon C., et al. Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J Biol Chem 275 (2000) 39507-39515
52. Hofmann U.B., Westphal J.R., Van Muijen G.N., and Ruiter D.J. Matrix metalloproteinases in human melanoma. J Invest Dermatol 115 (2000) 337-344
53. Rundhaug J.E., Pavone A., Kim E., and Fischer S.M. The role of topical cyclo-oxygenase-2 inhibitors in skin cancer: treatment and prevention. Mol Carcinog 46 (2007) 981-992